Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024
Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014
Clinicopath Conf, Multiple-System Atrophy
NEJM 351:912-921, Case 27-2004, 2004
Wolfram Syndrome:Hereditary Diabetes Mellitus with Brainstem and Optic Atrophy
Ann Neurol 39:352-360, Scolding,N.J.,et al, 1996
Severe Tetanus in Immunized Patients with High Anti-Tetanus Titers
Neurol 42:761-764, Crone,N.E.&Reder,A.T., 1992
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Clinical Assessment of 31 Patients with Wilson's Disease, Correlations with Struct. Changes on MRI
Arch Neurol 44:365-370, Starosta-Rubinstein,S.,et al, 1987
Neuroleptic Malignant Syndrome:Review and Analysis of 115 Cases
Biol Psychiatry 22:1004-1020, Addonizio,G.,et al, 1987
The Neuroleptic Malignant Syndrome
Arch Int Med 142:1183-1185, Smego,R.A.,et al, 1982
Neuroleptic Malignant Syndrome:A Pathogenetic Role for Dopamine Receptor Blockage
Neurol 31:132-137, Henderson,V.W.,et al, 1981